Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

BIOSEARCH TECHNOLOGIES INC (Lucigen) ClearColi BL21(DE3) Electrocompetent Cells, 24 Rxns (DUOs)Eliminate endotoxin at the source with this unique engineered E. coli strain for low-endotoxin protein expression.

Supplier:  BIOSEARCH TECHNOLOGIES INC 608102

Encompass_Preferred

Eliminate endotoxin at the sourceGenetically modified LPS does not trigger endotoxic response in human cellsIdeal for mammalian cell immunogenicity testing, toxicity assays, and therapeutic protein drug discoveryUseful for membrane and lipid binding protein productionProtein expression similar to BL21(DE3) cells without requiring downstream endotoxin removalReduce false positives in cytokine assays, improve confidence in your resultsEach ClearColi BL21(DE3) Electrocompetent Cell Kit contains: ClearColi BL21(DE3) Electrocompetent Cells in DUO packaging (2 transformations per tube), Expression Recovery Medium (lactose minus), pUC19 Positive Control Plasmid, and complete protocols.Expression Recovery Medium (lactose minus) is also available separately.

Catalog No. NC2162034


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.